This study was undertaken to investigate the effects of melanocortins
and opioids on rat early postnatal body and organ growth. Among melano
cortins tested desacetyl-alpha-melanocyte-stimulating hormone (alpha-M
SH) at dosages of 0.3 and 3 mu g/g/day was effective in stimulating ne
onatal growth with a weight gain of 7 and 5.6%, respectively, after 2
weeks of treatment. Likewise, a weight rise of 4.2 and 3% was obtained
with 3 mu g/g/day of both alpha-MSH and Nle(4)-D-Phe(7) alpha-MSH. As
far as opioids were concerned, while N-acetyl-beta-endorphin (beta-En
d) was ineffective, the activity of beta-End was dependent on dosage.
Indeed, newborns treated with 0.03 mu g/g/day showed a slight, but sig
nificant, increase in weight, whereas a marked decrease in growth foll
owed treatment with 0.3 and, mainly, 3 mu g/g/day, with a final weight
loss of 3.4 and 5.5%, respectively. All melanocortins exerted a posit
ive action on muscular and brain trophism and, in addition, desacetyl-
alpha-MSH also induced a rise of fat deposits. On the contrary, while
the 0.03 mu g/g/day beta-End dose caused an increase in muscular and b
rain weight, the higher dosages of the opioid were detrimental, not on
ly for muscle and brain, but also for both liver and spleen weight. A
slight, although significant (P < 0.05), enhancement of serum dehydroe
piandrosterone sulfate (DHEAS) level was found after the injection of
0.3 mu g/g desacetyl-alpha-MSH, whereas both the 0.3 and 3 mu g/g dose
s of desacetyl-alpha-MSH and the 3 mu g/g dose of alpha-MSH determined
the rise of plasma androstenedione (P < 0.05). All tested melanocorti
ns and opioids failed to modify the concentrations of corticosterone.
Our results suggest that melanocortins and opioids can modulate early
postnatal growth in rats either by direct or indirect mechanisms.